Lubartów, Poland

Andzelika Najda

This inventor holds 1 USPTO granted patent. Top assignees: Instytut Biochemii I Biofizyki, Instytut Medycyny Doswiadczalnej I Kliniczne, National Institute of Health and Medical Research. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andzelika Najda. Retrieved from https://idiyas.com/inventor/andzelika-najda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andzelika Najda: Innovator in Pharmaceutical Chemistry

Introduction

Andzelika Najda is a notable inventor based in Lubartow, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug derivatives.

Latest Patents

Najda holds a patent for "Derivatives of epirubicin, their medicinal application and pharmaceutically acceptable forms of drugs." This invention relates to innovative derivatives of epirubicin, a well-known chemotherapeutic agent. The patent outlines pharmaceutical compositions that include these derivatives and their applications in treating Hepatitis C Virus (HCV).

Career Highlights

Throughout her career, Andzelika Najda has worked with esteemed institutions such as the Institute of Biochemistry and Biophysics and the National Institute of Health and Medical Research. Her work has focused on advancing medical treatments through innovative pharmaceutical solutions.

Collaborations

Najda has collaborated with notable colleagues, including Tadeusz Kulikowski and Maria Bretner, who have contributed to her research endeavors.

Conclusion

Andzelika Najda's work in pharmaceutical chemistry exemplifies the impact of innovation in medicine. Her contributions continue to influence the development of effective treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…